UNVERIFIEDSingle Source
STAT+: Psychedelic biotechs face scrutiny over YouTube promos
Stat News|3/31/2026
DD
drug development
197 stories tracked
Executive summary being generated...
Lindy
0
Breaking
0
Unverified
99
Activity (Last 30 Days)
2
2
1
4
2
2
1
3
2
1
3
2
1
1
4
2
1
1
2
5
2
2
2026-03-052026-04-02
Top Publishers
Stat News96 stories
MIT News3 stories
Stories (Latest First)
UNVERIFIEDSingle Source
STAT+: Biogen to acquire immunology biotech Apellis for $5.6 billion
Stat News|3/31/2026
UNVERIFIEDSingle Source
STAT+: Eli Lilly to buy Centessa Pharmaceuticals, maker of a narcolepsy drug, in $6.3B deal
Stat News|3/31/2026
UNVERIFIEDSingle Source
STAT+: Over-the-top psychedelic promos could undermine the field’s drug development efforts
Stat News|3/31/2026
UNVERIFIEDSingle Source
STAT+: Biogen lupus drug improves skin clearance in mid-stage study
Stat News|3/30/2026
UNVERIFIEDSingle Source
STAT+: Allogene’s off-the-shelf CAR-T is nearing an early but pivotal study readout
Stat News|3/26/2026
UNVERIFIEDSingle Source
STAT+: FDA approves Denali Therapeutics drug for Hunter syndrome
Stat News|3/25/2026
UNVERIFIEDSingle Source
STAT+: Sarepta Therapeutics shares rise on early promise for rare disease drugs
Stat News|3/25/2026
UNVERIFIEDSingle Source
STAT+: Gilead to acquire immunology biotech, offers lifeline to Galapagos
Stat News|3/24/2026
UNVERIFIEDSingle Source
STAT+: Novartis picks up experimental breast cancer therapy for $2B
Stat News|3/20/2026
UNVERIFIEDSingle Source
STAT+: Eli Lilly’s ‘triple-G’ drug leads to significant blood sugar, weight reductions in diabetes trial
Stat News|3/19/2026
UNVERIFIEDSingle Source
STAT+: Six drugmakers, six months: Charting the FDA’s course in the post-Prasad era
Stat News|3/19/2026
UNVERIFIEDSingle Source
STAT+: Senator blasts GSK inhaler practices, calls for reform
Stat News|3/17/2026
UNVERIFIEDSingle Source
STAT+: Structure Therapeutics reports significant weight loss from mid-stage GLP-1 pill
Stat News|3/16/2026
UNVERIFIEDSingle Source
STAT+: A top biotech VC quietly helped Epstein’s ‘great friend’ make a comeback
Stat News|3/11/2026
UNVERIFIEDSingle Source
STAT+: Xenon Pharmaceuticals’ seizure drug shows strong efficacy in late-stage trial
Stat News|3/9/2026
UNVERIFIEDSingle Source
Vinay Prasad, key Makary ally and a focus of controversy at the FDA, is leaving the agency
Stat News|3/6/2026
UNVERIFIEDSingle Source
Opinion: AI could revolutionize antibiotics — but the market is standing in the way
Stat News|3/5/2026
UNVERIFIEDSingle Source
STAT+: Moderna to pay Roivant up to $2.25 billion to settle patent lawsuit behind mRNA vaccines
Stat News|3/3/2026
UNVERIFIEDSingle Source
STAT+: Prime Medicine to seek approval for gene editing treatment after two-patient trial
Stat News|3/3/2026
UNVERIFIEDSingle Source
STAT+: CMS wants more drugmakers to join Medicaid ‘most-favored nations’ pilot
Stat News|3/3/2026
UNVERIFIEDSingle Source
STAT+: UniQure plans to seek approval for Huntington’s therapy still blocked by FDA
Stat News|3/2/2026
UNVERIFIEDSingle Source
STAT+: Novo Nordisk strikes deal with U.S. startup to develop oral obesity, diabetes drugs
Stat News|2/25/2026
UNVERIFIEDSingle Source
STAT+: New treatment approach could give IBD patients hope, and be a bonanza for drugmakers
Stat News|2/24/2026
UNVERIFIEDSingle Source
STAT+: Novo’s next-gen obesity drug stumbles in Lilly comparison study
Stat News|2/23/2026
UNVERIFIEDSingle Source
STAT+: What to expect from Gossamer Bio’s late-stage lung disease study
Stat News|2/19/2026
UNVERIFIEDSingle Source
STAT+: Biotech startup raises $175 million to advance Alzheimer’s antibody therapy
Stat News|2/18/2026
UNVERIFIEDSingle Source
STAT+: The health care economy, and a surprising Humira chart
Stat News|2/17/2026
UNVERIFIEDSingle Source
STAT+: FDA’s rejection of Moderna threatens to stifle broader vaccine industry
Stat News|2/12/2026
UNVERIFIEDSingle Source
STAT+: The old Vinay Prasad never left. He just changed jobs
Stat News|2/12/2026
UNVERIFIEDSingle Source
Opinion: My granddaughter has a rare disease. But clinical trials often exclude patients like her
Stat News|2/11/2026
UNVERIFIEDSingle Source
3 Questions: Using AI to accelerate the discovery and design of therapeutic drugs
MIT News|2/4/2026
UNVERIFIEDSingle Source
STAT+: Why Bristol Myers Squibb believes a decades-old drug can treat Alzheimer’s
Stat News|2/2/2026
UNVERIFIEDSingle Source
STAT+: As its immunology work draws attention, Sanofi also pushes forward in rare disease
Stat News|2/2/2026